ArticleInternational urology and nephrology2019

Febuxostat is superior to allopurinol in delaying the progression of renal impairment in patients with chronic kidney disease and hyperuricemia.

Xin Zhang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.